These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 1303649

  • 1. Screening for neuroblastoma in the north of England.
    Parker L, Craft AW, Dale G, Bell S, Cole M, McGill AC, Seviour JA, Smith J.
    BMJ; 1992 Nov 21; 305(6864):1260-3. PubMed ID: 1303649
    [Abstract] [Full Text] [Related]

  • 2. False positive results in a neuroblastoma screening programme.
    Bell S, Parker L, Craft AW, Dale G, McGill AC, Seviour J, Cole M, Smith J.
    Med Pediatr Oncol; 1994 Nov 21; 22(3):181-6. PubMed ID: 8272007
    [Abstract] [Full Text] [Related]

  • 3. Creatinine related reference ranges for urinary homovanillic acid and vanillylmandelic acid at 6 months of age.
    Cole M, Parker L, Craft AW, Bell S, Dale G, McGill AC, Seviour JA, Smith J.
    Arch Dis Child; 1993 Mar 21; 68(3):376-8. PubMed ID: 8466241
    [Abstract] [Full Text] [Related]

  • 4. Screening for neuroblastoma in the northern region of England. Laboratory aspects.
    Seviour JA, McGill AC, Craft AW, Parker L, Bell S, Cole M, Smith J, Hawkins E, Brown J, Dale GA.
    Am J Pediatr Hematol Oncol; 1992 Nov 21; 14(4):332-6. PubMed ID: 1456399
    [Abstract] [Full Text] [Related]

  • 5. A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observations.
    Mathieu P, Frappaz D, Chauvin F, Combaret V, Vercherat M, Brunat-Mentigny M, David L, Esteve J, Favrot M, Fouillat V, Greffe J, Lasset C, Renaud P, Philip T.
    Early Hum Dev; 1996 Sep 20; 46(1-2):177-96. PubMed ID: 9019414
    [Abstract] [Full Text] [Related]

  • 6. Simple liquid-chromatographic measurement of vanillylmandelic acid and homovanillic acid in urine on filter paper for mass screening of neuroblastoma in infants.
    Hanai J, Kawai T, Sato Y, Takasugi N, Nishi M, Takeda T.
    Clin Chem; 1987 Nov 20; 33(11):2043-6. PubMed ID: 3677377
    [Abstract] [Full Text] [Related]

  • 7. A pilot study of screening for neuroblastoma in the north of England.
    Craft AW, Parker L, Dale G, McGill AC, Seviour JA, Bell S, Cole M, Smith J.
    Am J Pediatr Hematol Oncol; 1992 Nov 20; 14(4):337-41. PubMed ID: 1456400
    [Abstract] [Full Text] [Related]

  • 8. Biochemical screening for neuroblastoma in infants: a feasibility study.
    Craft AW, Dale G, McGill A, Seviour J, Spence EM.
    Med Pediatr Oncol; 1989 Nov 20; 17(5):373-8. PubMed ID: 2796853
    [Abstract] [Full Text] [Related]

  • 9. Thin-layer chromatography of urinary homovanillic acid and vanillylmandelic acid for large-scale neuroblastoma mass screening.
    Auray-Blais C, Giguère R, Lemieux B.
    Med Pediatr Oncol; 1989 Nov 20; 17(5):364-7. PubMed ID: 2796851
    [No Abstract] [Full Text] [Related]

  • 10. Vanillylmandelic acid, homovanillic acid, and catecholamines in urine of infants with neuroblastoma 6- to 11-month-old.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1986 Dec 20; 16(4):351-5. PubMed ID: 3795531
    [Abstract] [Full Text] [Related]

  • 11. Establishment of cut off values for vanillylmandelic acid and homovanillic acid in 24-hr urine accumulation during mass screening for neuroblastoma.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1987 Sep 20; 17(3):221-8. PubMed ID: 3669365
    [Abstract] [Full Text] [Related]

  • 12. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project.
    Tuchman M, Lemieux B, Auray-Blais C, Robison LL, Giguere R, McCann MT, Woods WG.
    Pediatrics; 1990 Nov 20; 86(5):765-73. PubMed ID: 2152340
    [Abstract] [Full Text] [Related]

  • 13. Feasibility study for neonatal neuroblastoma screening in the United States.
    Tuchman M, Fisher EJ, Heisel MA, Woods WG.
    Med Pediatr Oncol; 1989 Nov 20; 17(4):258-64. PubMed ID: 2747596
    [Abstract] [Full Text] [Related]

  • 14. Seasonal variations in vanillylmandelic acid and homovanillic acid in infants' urine.
    Nishi M, Miyake H, Takeda T, Takasugi N, Sato Y, Hanai J.
    Jpn J Clin Oncol; 1987 Jun 20; 17(2):151-5. PubMed ID: 3613139
    [Abstract] [Full Text] [Related]

  • 15. Can mass screening for neuroblastoma detect patients with low vanillylmandelic acid and high homovanillic acid?
    Nishi M, Miyake H, Takeda T, Takasugi N, Hanai J, Kawai T.
    Acta Paediatr Jpn; 1989 Dec 20; 31(6):742-4. PubMed ID: 2516402
    [No Abstract] [Full Text] [Related]

  • 16. Screening for neuroblastoma: a review of the evidence.
    Chamberlain J.
    J Med Screen; 1994 Jul 20; 1(3):169-75. PubMed ID: 8790511
    [Abstract] [Full Text] [Related]

  • 17. Urinary vanillylmandelic acid and homovanillic acid levels in randomly-sampled urine for the mass screening of neuroblastoma.
    Nishi M, Miyake H, Takeda T, Takasugi N, Hanai J, Kawai T.
    Jpn J Clin Oncol; 1990 Sep 20; 20(3):268-70. PubMed ID: 2255102
    [Abstract] [Full Text] [Related]

  • 18. Determination of urinary vanillylmandelic acid and homovanillic acid by high performance liquid chromatography for mass screening of neuroblastoma.
    Sato Y, Hanai J, Takasugi N, Takeda T.
    Tohoku J Exp Med; 1986 Oct 20; 150(2):169-74. PubMed ID: 3810642
    [Abstract] [Full Text] [Related]

  • 19. Screening for neuroblastoma in France: methodological aspects and preliminary observations.
    Chauvin F, Mathieu P, Frappaz D, Lasset C, Favrot MC, Greffe J, Esteve J, Thiesse P, Combaret V, Chauvot P, Boschetti R, David L, Brunat-Mentigny M, Philip T.
    Med Pediatr Oncol; 1997 Feb 20; 28(2):81-91. PubMed ID: 8986143
    [Abstract] [Full Text] [Related]

  • 20. Three years of experience with random urinary homovanillic and vanillylmandelic acid levels in the diagnosis of neuroblastoma.
    Tuchman M, Ramnaraine ML, Woods WG, Krivit W.
    Pediatrics; 1987 Feb 20; 79(2):203-5. PubMed ID: 3808793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.